Strattera vs Qelbree — Comparison & Availability

StratteraQelbree
Brand NameStratteraQelbree
Generic Nameatomoxetineviloxazine ER
Drug ClassSNRI (non-stimulant ADHD)Non-stimulant ADHD (SNRI)
Findability Score66/10066/100
FindabilityModerateModerate
Avg Pharmacy Calls~10~10

Which Is Easier to Find Right Now?

Both Strattera and Qelbree have similar findability scores of 66/100. You may need to call around 10 pharmacies to locate either one. Let FindUrMeds do the searching for you.

Key Differences Between Strattera and Qelbree

Strattera (atomoxetine) is a SNRI (non-stimulant ADHD), while Qelbree (viloxazine ER) is a Non-stimulant ADHD (SNRI). These different drug classes mean they work through distinct mechanisms in the body, which can affect efficacy, side effects, and suitability for different patients.

Because they belong to different classes, switching between Strattera and Qelbree is a decision that should be made carefully with your healthcare provider, who can weigh the benefits and risks for your particular situation.

Frequently Asked Questions

Is Strattera or Qelbree easier to find?

Based on current availability data, Strattera has a Findability Score of 66/100 compared to Qelbree's 66/100. Strattera typically requires about 10 pharmacy calls to locate, while Qelbree may take around 10 calls.

Can I switch from Strattera to Qelbree?

Switching between Strattera and Qelbree requires a conversation with your prescribing doctor. They can evaluate whether the switch is appropriate based on your medical history, current condition, and how you've responded to your current medication. Never switch medications without medical guidance.

Which is cheaper, Strattera or Qelbree?

Prices vary by pharmacy, insurance coverage, and whether a generic is available. Strattera (generic: atomoxetine) and Qelbree (generic: viloxazine ER) may have different out-of-pocket costs depending on your plan. Using GoodRx coupons or asking your pharmacist about generic alternatives can help reduce costs for either medication.

Summarize this article with AI:

Learn More